Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PRIZM and Chiron begin gene therapy collaboration

June 5, 1997

Matrix Pharmaceutical's AccuSite recommended for approval in six European countries

June 4, 1997

Immunomedics' antibody therapy for non-Hodgkin's lymphoma shows promise in clinical trial

June 4, 1997

Banyu developing new anticancer agent

June 4, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Receptagen receives notice of allowance of U.S. patent for "growth blocker" technology

June 3, 1997

Alpha Therapeutic and Techniclone report milestone in LYM-1 clinical development

June 3, 1997

Schering-Plough's Fareston approved by the FDA

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...